A detailed history of Orbimed Advisors LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 23,500 shares of KRYS stock, worth $4.01 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
23,500
Previous 29,966 21.58%
Holding current value
$4.01 Million
Previous $5.5 Million 22.34%
% of portfolio
0.1%
Previous 0.13%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$174.7 - $213.66 $1.13 Million - $1.38 Million
-6,466 Reduced 21.58%
23,500 $4.27 Million
Q2 2024

Aug 14, 2024

SELL
$153.12 - $183.64 $1.1 Million - $1.32 Million
-7,200 Reduced 19.37%
29,966 $5.5 Million
Q1 2024

May 15, 2024

SELL
$108.01 - $179.35 $7.19 Million - $11.9 Million
-66,534 Reduced 64.16%
37,166 $6.61 Million
Q4 2023

Feb 14, 2024

BUY
$96.0 - $128.29 $9.96 Million - $13.3 Million
103,700 New
103,700 $12.9 Million
Q1 2020

May 15, 2020

SELL
$35.02 - $65.64 $34.8 Million - $65.3 Million
-994,808 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$33.17 - $65.23 $13 Million - $25.6 Million
392,858 Added 65.26%
994,808 $55.1 Million
Q3 2019

Nov 14, 2019

SELL
$34.72 - $51.3 $1.39 Million - $2.05 Million
-40,056 Reduced 6.24%
601,950 $20.9 Million
Q2 2019

Aug 14, 2019

BUY
$27.2 - $41.2 $15.9 Million - $24 Million
582,796 Added 984.29%
642,006 $25.9 Million
Q1 2019

May 15, 2019

BUY
$19.86 - $32.9 $1.18 Million - $1.95 Million
59,210 New
59,210 $1.95 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.38B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.